Health Condition 1: M959- Acquired deformity of musculoskeletal system, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient who are willing to participate in the study and ready to give a written informed consent. 2. Subjects of either sex in the age group of 40 years to 70 years. 3. Pain and stiffness with motion in the effected shoulder joint. 4. Limitation of passive movement in the glenohumeral joint compared with the unaffected side, more than 30 degrees for at least two of these three movements: forward flexion, abduction or external rotation.
Exclusion criteria
Exclusion criteria: 1. The subjects who are known to have congenital abnormality of the shoulder joint and/or upper limb, osteoarthritis of shoulder joint, rheumatoid arthritis and other autoimmune diseases, malignancies, history of any trauma, fracture or dislocation related to the shoulder joint, or surgical history to the joint. 2. Patient who has been administered intra-articular injection into the affected shoulder joint or invasive measures have been performed at the affected joint or systemic medication with corticosteroids during the preceding 3 months. 3. Patients with diabetes and hyper or hypo thyroidism. 4. Pregnant or lactating women. 5. Patients with an acute mental disorder, a serious acute organic disease, or any serious comorbidity that made it impossible to participate in the trial interventions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| improvement in range of movement of shoulder jointTimepoint: 0-day, 15th day and 30th day | — |
Secondary
| Measure | Time frame |
|---|---|
| assessment of any adverse drug reactionTimepoint: 30 days | — |
Countries
India
Contacts
North Eastern Institute of Ayurveda and Homoeopathy, Shillong